practolol has been researched along with Myocardial Infarction in 123 studies
Practolol: A beta-1 adrenergic antagonist that has been used in the emergency treatment of CARDIAC ARRYTHMIAS.
practolol : N-(4-Hydroxyphenyl)acetamide in which the hydrogen of the phenolic hydroxy group is substituted by a 3-(isopropylaminoamino)-2-hydroxypropyl group. A selective beta blocker, it has been used in the emergency treatment of cardiac arrhythmias.
Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eighty-seven patients with an acute myocardial infarction and a pulse rate of greater than or equal to 80/min on admission were randomly allotted to one group given cardioselective beta-blockade, a second group given diazepam, and a third group given placebo." | 9.05 | A comparative study of cardioselective beta-blockade and diazepam in patients wtih acute myocardial infarction and tachycardia. ( Johansson, BW, 1980) |
| "In a large-scale double-blind controlled trial of practolol (200 mg twice daily) in the long-term prophylactic treatment of 3038 patients recovering from acute myocardial infarction treatment was started one to four weeks after the acute attack." | 9.04 | Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol. A multicentre international study. ( , 1975) |
| "In a double-blind controlled trial lasting 12 months, long-term practolol therapy had no significant effect on plasma-lipid concentrations in twenty patients who had had acute myocardial infarction." | 9.04 | Effects of long-term practolol therapy on plasma-lipids after acute myocardial infarction. ( Cochrane, AM; de Bono, D; Ghosh, P, 1975) |
| "The influence of routine administration of the beta adrenoceptor blocking drug practolol on the outcome of acute myocardial infarction has been studied in 94 patients." | 9.04 | Intravenous and oral practolol in the acute stages of myocardial infarction. ( Evemy, KL; Pentecost, BL, 1978) |
| "Eleven patients with cardiogenic shock following acute myocardial infarction (AMI) have been treated with prenalterol." | 7.67 | Prenalterol in cardiogenic shock following acute myocardial infarction. ( Coma-Canella, I; Jadraque, LM; Lopez-Sendon, J, 1984) |
| "In order to assess regional myocardial contractile responses to the beta-adrenergic stimulant prenalterol after recent myocardial infarction, 9 male mongrel dogs underwent left circumflex coronary artery (LCX) occlusion after implantation of miniature subendocardial sonomicrometer crystals in normal, marginally ischemic (border) and central ischemic zones." | 7.67 | Regional myocardial contractile response to the beta-adrenergic stimulant prenalterol in the conscious dog following myocardial infarction. Mechanism of hemodynamic effect. ( Kirlin, PC; Lucchesi, B; Pitt, B; Romson, JL, 1984) |
| "The haemodynamic effects of prenalterol, a new selective beta-1 adrenoreceptor agonist, have been studied in patients with coronary heart disease." | 7.66 | Haemodynamic effects of prenalterol in patients with coronary heart disease. ( Boyes, RN; Hillis, WS; Hutton, I; Murray, RG; Rae, AP, 1980) |
| "Five patients with acute myocardial infarction and shock were treated with a new, highly selective beta-1-adrenoreceptor agonist, prenalterol." | 7.66 | Hemodynamic and cardiometabolic effects of prenalterol in patients with acute myocardial infarction and shock. ( Friedman, A; Häggmark, S; Reiz, S, 1981) |
| "The ability of practolol and propranolol of prevent ventricular fibrillation in experimental anterior myocardial infarction was compared in dogs subjected to ligation of the left anterior descending and first septal coronary arteries." | 7.66 | Superiority of practolol versus propranolol in protection against ventricular fibrillation induced by coronary occlusion. ( Gillis, RA; Pearle, DL; Williford, D, 1978) |
| "Practolol is a cardio-selective beta-blocking agent with an intrinsic sympathomimetic action, but devoid of local anaesthetic effect." | 6.64 | Practolol in acute myocardial infarction. ( Barber, JM; Boyle, DM; Chaturvedi, NC; Singh, N; Walsh, MJ, 1976) |
| " Three days post-AMI the dose-response curve for isoproterenol of right ventricular dP/dtmax was significantly depressed, while the inotropic effect of impromidine was not impaired." | 5.27 | Apparent superiority of H2-receptor stimulation and simultaneous beta-blockade over conventional treatment with beta-sympathomimetic drugs in post-acute myocardial infarction: cardiac effects of impromidine--a new specific H2-receptor agonist-in the survi ( Baumann, G; Blömer, H; Felix, SB; Heidecke, CD; Loher, U; Ludwig, L; Riess, G, 1984) |
| "The arrhythmias were prevented by higher doses of the calcium antagonist verapamil which, however, decreased the survival times." | 5.26 | Comparative investigation of the effects of metoprolol, propranolol, practolol, and verapamil in the acute phase of experimental myocardial infarction. ( Bernauer, W, 1982) |
| "1 The effects of propranolol and practolol, at equivalent myocardial beta-adrenoceptor blocking doses, (as assessed by the degree of shift of isoprenaline dose-response curves) were investigated in anaesthetized greyhounds before and after acute coronary artery ligation." | 5.26 | Comparative effects of propranolol and practolol in the early stages of experimental canine myocardial infarction. ( Marshall, RJ; Parratt, JR, 1976) |
| "Eighty-seven patients with an acute myocardial infarction and a pulse rate of greater than or equal to 80/min on admission were randomly allotted to one group given cardioselective beta-blockade, a second group given diazepam, and a third group given placebo." | 5.05 | A comparative study of cardioselective beta-blockade and diazepam in patients wtih acute myocardial infarction and tachycardia. ( Johansson, BW, 1980) |
| "Fifty-five patients with recent acute myocardial infarction entered a single-blind cross-over trial to assess the effect of oral practolol 200 mg twice daily on the incidence and nature of ventricular arrhythmias in the first year following myocardial infarction." | 5.05 | The effect of a selective beta adrenergic blocking agent on ventricular arrhythmias in the first year following myocardial infarction. ( Anderson, ST; Federman, J; Pitt, A; Whitford, JA, 1980) |
| "A double-blind study including three different cardioselective beta-blockers, practolol, H 87/07 and metoprolol, was performed in 54 patients with acute myocardial infarction and chest pain shortly after onset of symptoms." | 5.04 | Double-blind study of the effect of cardioselective beta-blockade on chest pain in acute myocardial infarction. ( Hjalmarson, AC; Waagstein, F, 1976) |
| "In a large-scale double-blind controlled trial of practolol (200 mg twice daily) in the long-term prophylactic treatment of 3038 patients recovering from acute myocardial infarction treatment was started one to four weeks after the acute attack." | 5.04 | Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol. A multicentre international study. ( , 1975) |
| "In a double-blind controlled trial lasting 12 months, long-term practolol therapy had no significant effect on plasma-lipid concentrations in twenty patients who had had acute myocardial infarction." | 5.04 | Effects of long-term practolol therapy on plasma-lipids after acute myocardial infarction. ( Cochrane, AM; de Bono, D; Ghosh, P, 1975) |
| "In a controlled multicentre trial carried out to assess the value of long-term practolol treatment after myocardial infarction the provisional results showed a significant reduction in mortality, though some of the data were lacking." | 5.04 | Reduction in mortality after myocardial infarction with long-term beta-adrenoceptor blockade. Multicentre international study: supplementary report. ( , 1977) |
| "The influence of routine administration of the beta adrenoceptor blocking drug practolol on the outcome of acute myocardial infarction has been studied in 94 patients." | 5.04 | Intravenous and oral practolol in the acute stages of myocardial infarction. ( Evemy, KL; Pentecost, BL, 1978) |
| "Eleven patients with cardiogenic shock following acute myocardial infarction (AMI) have been treated with prenalterol." | 3.67 | Prenalterol in cardiogenic shock following acute myocardial infarction. ( Coma-Canella, I; Jadraque, LM; Lopez-Sendon, J, 1984) |
| "Prenalterol was given to twenty five patients with acute myocardial infarction." | 3.67 | Haemodynamic effects of prenaterol and cardiac glycosides in patients with recent myocardial infarction. ( Andersson, J; Boström, PA; Johansson, BW; Lilja, B; Thorell, J; Tidfält, K; Westerling, S, 1984) |
| "In order to assess regional myocardial contractile responses to the beta-adrenergic stimulant prenalterol after recent myocardial infarction, 9 male mongrel dogs underwent left circumflex coronary artery (LCX) occlusion after implantation of miniature subendocardial sonomicrometer crystals in normal, marginally ischemic (border) and central ischemic zones." | 3.67 | Regional myocardial contractile response to the beta-adrenergic stimulant prenalterol in the conscious dog following myocardial infarction. Mechanism of hemodynamic effect. ( Kirlin, PC; Lucchesi, B; Pitt, B; Romson, JL, 1984) |
| "The haemodynamic effects of prenalterol, a new selective beta-1 adrenoreceptor agonist, have been studied in patients with coronary heart disease." | 3.66 | Haemodynamic effects of prenalterol in patients with coronary heart disease. ( Boyes, RN; Hillis, WS; Hutton, I; Murray, RG; Rae, AP, 1980) |
| "The ability of practolol and propranolol of prevent ventricular fibrillation in experimental anterior myocardial infarction was compared in dogs subjected to ligation of the left anterior descending and first septal coronary arteries." | 3.66 | Superiority of practolol versus propranolol in protection against ventricular fibrillation induced by coronary occlusion. ( Gillis, RA; Pearle, DL; Williford, D, 1978) |
| "Five patients with acute myocardial infarction and shock were treated with a new, highly selective beta-1-adrenoreceptor agonist, prenalterol." | 3.66 | Hemodynamic and cardiometabolic effects of prenalterol in patients with acute myocardial infarction and shock. ( Friedman, A; Häggmark, S; Reiz, S, 1981) |
| "The hemodynamic effects of prenalterol, a parenteral cardioselective beta 1-receptor agonist, were evaluated by cardiac catheterization in patients with refractory severe congestive heart failure (CHF)." | 3.66 | The hemodynamic actions of prenalterol in left ventricular failure. ( Awan, NA; Evenson, MK; Mason, DT; Needham, KE, 1982) |
| "The cardiovascular effects of halothane-nitrous oxide anesthesia, and beta-receptor blockade with either propranolol or practolol, were studied in 15 dogs in which severe myocardial infarction had been induced ten days earlier." | 3.65 | Interaction of anesthesia, beta-receptor blockade, and blood loss in dogs with induced myocardial infarction. ( Bennett, MJ; Clarke, TN; Foëx, P; Prys-Roberts, C; Roberts, JG; Ryder, WA, 1976) |
| " In 10 patients with acute myocardial infarction and recurrent chest pain recordings on noninvasive parameters were made before and 30 min after intravenous injection of practolol." | 3.65 | Effect of cardioselective beta-blockade on heart function and chest pain in acute myocardial infarction. ( Hjalmarson, AC; Waagstein, F, 1976) |
| "In animals without myocardial infarction the new beta-sympathicolytic agent atenolol (4-[2'-hydroxy-3'-iso-propylaminopropoxy]-phenyl acetamide, ICI 66 082) dose-dependently decreased heart rate, systolic aortic pressure and cardiac output." | 3.65 | [The effect of atenolol on contractility and hemodynamics of the infarcted heart in comparison to propranolol and practolol (author's transl)]. ( Bischoff, KO; Diesch, J; Geigenmüller, L; Hübner, H; Meesmann, W; Stephan, K, 1975) |
| "Practolol is a cardio-selective beta-blocking agent with an intrinsic sympathomimetic action, but devoid of local anaesthetic effect." | 2.64 | Practolol in acute myocardial infarction. ( Barber, JM; Boyle, DM; Chaturvedi, NC; Singh, N; Walsh, MJ, 1976) |
| " Three days post-AMI the dose-response curve for isoproterenol of right ventricular dP/dtmax was significantly depressed, while the inotropic effect of impromidine was not impaired." | 1.27 | Apparent superiority of H2-receptor stimulation and simultaneous beta-blockade over conventional treatment with beta-sympathomimetic drugs in post-acute myocardial infarction: cardiac effects of impromidine--a new specific H2-receptor agonist-in the survi ( Baumann, G; Blömer, H; Felix, SB; Heidecke, CD; Loher, U; Ludwig, L; Riess, G, 1984) |
| "The extent of subendocardial scar was similar in both groups but subepicardial scar formation was significantly less in group A." | 1.27 | Effects of beta-adrenergic inhibition on scar formation after myocardial infarction. ( Haider, B; Jenkins, B; Ravindranathan, MP; Regan, TJ, 1984) |
| " What remains to be solved is the dosage level." | 1.26 | Clinical experiences with prenalterol as an antidote to Beta-adrenoceptor blockade. ( Kulling, P, 1982) |
| "The arrhythmias were prevented by higher doses of the calcium antagonist verapamil which, however, decreased the survival times." | 1.26 | Comparative investigation of the effects of metoprolol, propranolol, practolol, and verapamil in the acute phase of experimental myocardial infarction. ( Bernauer, W, 1982) |
| "Experience with treatment of myocardial infarction in man has shown that beta-blocking agents are well tolerated in patients presenting in hemodynamically stable condition (Killip groups I and II)." | 1.26 | [Use of beta-adrenergic blocking agents in acute myocardial infarction (author's transl)]. ( Himmler, FC; Klein, G; Schmidt, G; Wirtzfeld, A, 1981) |
| "Prenalterol was administered intravenously in four increasing doses to a cumulative dose of 5." | 1.26 | Central and peripheral haemodynamic effects of prenalterol in patients with coronary heart disease. ( Carlsen, JE; Hartling, OJ; Svendsen, TL; Trap-Jensen, J, 1981) |
| "Arrhythmias were studied at the early stage after rapid ligation of the left ventricular artery on an experimental model of arrhythmia in rabbits." | 1.26 | [Assessment of early arrhythmias in acute experimental myocardial infarct in rabbits]. ( Balea, FD; Figueroa, AA; LLuis, CN; Pérez, MG; Santos, AC, 1978) |
| "The effect is critically reviewed of chronic administration of beta-adrenoreceptor antagonists on morbidity and mortality in angina pectoris and myocardial infarction." | 1.26 | The effect of beta-adrenoreceptive antagonists on the morbidity and mortality in cardiovascular disease. ( Fitzgerald, JD, 1976) |
| "Most of those liable to sudden death can be identified and it is possible that by the use of beta-adrenergic blocking or other antiarrhythmic drugs, by reducing the consumption of cigarettes and perhaps, by different therapies for hypertension, a substantial proportion of coronary deaths might be prevented or, at least, postponed." | 1.26 | Toward preventing coronary death from ventricular fibrillation. ( Julian, DG, 1976) |
| "1 The effects of propranolol and practolol, at equivalent myocardial beta-adrenoceptor blocking doses, (as assessed by the degree of shift of isoprenaline dose-response curves) were investigated in anaesthetized greyhounds before and after acute coronary artery ligation." | 1.26 | Comparative effects of propranolol and practolol in the early stages of experimental canine myocardial infarction. ( Marshall, RJ; Parratt, JR, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 122 (99.19) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (0.81) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexopoulos, D | 1 |
| Goudevenos, JA | 1 |
| Xanthopoulou, I | 1 |
| Deftereos, S | 1 |
| Sitafidis, G | 1 |
| Kanakakis, I | 1 |
| Hamilos, M | 1 |
| Parissis, H | 1 |
| Ntalas, IV | 1 |
| Angelidis, C | 1 |
| Petousis, S | 1 |
| Vavuranakis, M | 1 |
| Hahalis, G | 1 |
| Stefanadis, C | 1 |
| Frishman, WH | 3 |
| Hutton, I | 1 |
| Murray, RG | 1 |
| Boyes, RN | 1 |
| Rae, AP | 1 |
| Hillis, WS | 1 |
| Schröder, R | 1 |
| Wirtzfeld, A | 1 |
| Klein, G | 1 |
| Himmler, FC | 1 |
| Schmidt, G | 1 |
| Hampton, JR | 2 |
| Reiz, S | 2 |
| Friedman, A | 1 |
| Häggmark, S | 1 |
| Vedin, A | 1 |
| Wilhelmsson, C | 1 |
| Frick, MH | 1 |
| Katila, M | 1 |
| Bernauer, W | 1 |
| Hjalmarson, A | 3 |
| Kulling, P | 1 |
| Waagstein, F | 5 |
| Estrada-Yamamoto, M | 1 |
| Reyes, C | 1 |
| Awan, NA | 1 |
| Evenson, MK | 1 |
| Needham, KE | 1 |
| Mason, DT | 1 |
| Doering, W | 1 |
| Wauer, B | 1 |
| Isbary, J | 1 |
| Dahlström, U | 1 |
| Karlsson, E | 1 |
| Staessen, J | 1 |
| Bulpitt, C | 1 |
| Cattaert, A | 1 |
| Fagard, R | 1 |
| Vanhees, L | 1 |
| Amery, A | 1 |
| Coma-Canella, I | 2 |
| Green, KG | 4 |
| Baber, NS | 1 |
| Lewis, JA | 2 |
| Pratt, CM | 1 |
| Roberts, R | 1 |
| Furberg, CD | 2 |
| Friedewald, WT | 2 |
| Lopez-Sendon, J | 1 |
| Jadraque, LM | 1 |
| Nelson, GI | 1 |
| Silke, B | 1 |
| Ahuja, RC | 1 |
| Walker, C | 1 |
| Forsyth, DR | 1 |
| Verma, SP | 1 |
| Taylor, SH | 1 |
| Ravindranathan, MP | 1 |
| Jenkins, B | 1 |
| Haider, B | 1 |
| Regan, TJ | 1 |
| Tomov, I | 1 |
| Boström, PA | 1 |
| Andersson, J | 1 |
| Johansson, BW | 2 |
| Lilja, B | 1 |
| Thorell, J | 1 |
| Tidfält, K | 1 |
| Westerling, S | 1 |
| Baumann, G | 1 |
| Felix, SB | 1 |
| Heidecke, CD | 1 |
| Riess, G | 1 |
| Loher, U | 1 |
| Ludwig, L | 1 |
| Blömer, H | 1 |
| Branzi, A | 2 |
| Binetti, G | 2 |
| Specchia, S | 2 |
| Magelli, C | 2 |
| Zannoli, R | 2 |
| Magnani, B | 2 |
| Smith, JW | 1 |
| Walsh, MJ | 3 |
| Chaturvedi, NC | 3 |
| Barber, J | 1 |
| Boyle, DM | 4 |
| Dłuzniewski, M | 1 |
| Zalewski, A | 1 |
| Budaj, A | 1 |
| Bednarz, B | 1 |
| Ceremuzyński, L | 2 |
| Kirlin, PC | 1 |
| Romson, JL | 1 |
| Pitt, B | 1 |
| Lucchesi, B | 1 |
| Federman, J | 2 |
| Whitford, JA | 2 |
| Anderson, ST | 2 |
| Pitt, A | 2 |
| Florkiewicz, H | 1 |
| Rymar, B | 1 |
| Przegaliński, J | 1 |
| Markiewicz, M | 1 |
| Pentecost, BL | 4 |
| Svendsen, TL | 1 |
| Carlsen, JE | 1 |
| Hartling, OJ | 1 |
| Trap-Jensen, J | 1 |
| Nordlander, R | 1 |
| Nyquist, O | 1 |
| García-Pérez, M | 2 |
| Nieto-Lluis, C | 2 |
| Dorticós, FR | 1 |
| Cabrera-Santos, AA | 1 |
| Thomas, M | 2 |
| Hjalmarson, AC | 3 |
| Ross, J | 1 |
| Norris, RM | 2 |
| Prys-Roberts, C | 2 |
| Roberts, JG | 2 |
| Foëx, P | 2 |
| Clarke, TN | 2 |
| Bennett, MJ | 1 |
| Ryder, WA | 1 |
| Fitzgerald, JD | 2 |
| Berdeaux, A | 1 |
| Peres da Costa, C | 1 |
| Garnier, M | 1 |
| Boissier, JR | 1 |
| Giudicelli, JF | 1 |
| Chamberlain, DA | 3 |
| Wilkinson, RK | 1 |
| Fanchamps, A | 1 |
| Ghosh, P | 1 |
| Cochrane, AM | 1 |
| de Bono, D | 1 |
| Gupta, KK | 1 |
| Cairns, JA | 1 |
| Herbaczyńska-Cedro, K | 1 |
| Broniszewska-Ardelt, B | 1 |
| Woźniewicz, B | 1 |
| Barber, JM | 3 |
| Singh, N | 1 |
| Fox, KM | 1 |
| Chopra, MP | 1 |
| Portal, RW | 1 |
| Aber, CP | 1 |
| Wit, AL | 1 |
| Hoffman, BF | 1 |
| Rosen, MR | 1 |
| Heikkilä, J | 1 |
| Nieminen, MS | 1 |
| Hunt, D | 2 |
| McRae, C | 2 |
| Ramshaw, J | 2 |
| Cole, P | 1 |
| Sloman, JG | 1 |
| LLuis, CN | 1 |
| Pérez, MG | 1 |
| Balea, FD | 1 |
| Santos, AC | 1 |
| Figueroa, AA | 1 |
| Evemy, KL | 1 |
| Pearle, DL | 1 |
| Williford, D | 1 |
| Gillis, RA | 1 |
| Waldenström, A | 1 |
| Zacharoulis, AA | 1 |
| Evans, TR | 1 |
| Ziady, GM | 1 |
| Coltart, DJ | 1 |
| Shillingford, JP | 1 |
| Julian, DG | 2 |
| Singh, VS | 1 |
| Mehrotra, TN | 1 |
| Kirti, S | 1 |
| Aran, RK | 1 |
| Elhance, GP | 1 |
| Pantridge, JF | 3 |
| Marshall, RJ | 2 |
| Parratt, JR | 2 |
| Rahi, AH | 1 |
| Chapman, CM | 1 |
| Garner, A | 1 |
| Wright, P | 1 |
| Fulton, RM | 2 |
| Hamer, NA | 2 |
| Oliver, MF | 2 |
| Wolter-Czerwińska, H | 1 |
| Filipowicz-Banachowa, AF | 1 |
| Hope, RR | 1 |
| Scherlag, BJ | 1 |
| El-Sherif, N | 1 |
| Lazzara, R | 1 |
| Sloman, G | 2 |
| Vormittag, E | 2 |
| Lekven, J | 1 |
| Schley, G | 1 |
| Meesmann, W | 3 |
| Wild, U | 2 |
| Vedin, JA | 1 |
| Wilhelmsson, CE | 1 |
| Mangiameli, S | 1 |
| Circo, A | 1 |
| Galassi, A | 1 |
| Stephan, K | 2 |
| Bischoff, KO | 2 |
| Hübner, H | 1 |
| Geigenmüller, L | 1 |
| Diesch, J | 1 |
| Barratt-Boyes, C | 1 |
| Heng, MK | 1 |
| Singh, BN | 2 |
| Geddes, JS | 1 |
| Cabrera-Santos, A | 1 |
| Fellenius, E | 1 |
| Hansen, CA | 1 |
| Mjøs, O | 1 |
| Neely, JR | 1 |
| Opolski, G | 2 |
| Korewicki, J | 2 |
| Jankowski, K | 2 |
| Ostrzycki, A | 2 |
| Zieliński, T | 2 |
| Sahn, SA | 1 |
| Bach-Mortensen, N | 1 |
| Mulholland, HC | 1 |
| Adornato, E | 1 |
| De Caridi, A | 1 |
| Figini, A | 1 |
| De Ponti, C | 1 |
| Campolo, L | 1 |
| Jewitt, DE | 1 |
| Davies, RO | 1 |
| Bardet, J | 1 |
| Rigaud, M | 1 |
| Rocha, P | 1 |
| Bourdarias, JP | 1 |
| Mathivat, A | 1 |
| Kundu, SC | 1 |
| De, AK | 1 |
| Majumdar, S | 1 |
| Wasir, HS | 1 |
| Rosettani, E | 1 |
| Mangiardi, L | 1 |
| Orzan, F | 1 |
| Bonamini, R | 1 |
| Casaccia, M | 1 |
| Brusca, A | 1 |
| Mond, H | 1 |
| Fenelon, A | 1 |
| Bloch, A | 1 |
| Horvat, L | 1 |
| Di Luzio, V | 1 |
| Purcaro, A | 1 |
| Curzi, G | 1 |
| Di Segni, E | 1 |
| Chiesa, R | 1 |
| Di Giuseppe, F | 1 |
| Jensen, G | 1 |
| Sigurd, B | 1 |
| Heller, A | 1 |
| Grosser, KD | 1 |
| Matlof, HJ | 1 |
| Bates, BL | 1 |
| Harrison, DC | 1 |
| Madan, BR | 1 |
| Jain, BK | 1 |
| Bennett, M | 1 |
| Lattke, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The GReek AntiPlatElet (GRAPE) Registry: A Multicenter Observational Prospective Investigation of Antiplatelet Treatment in Patients With Acute Coronary Syndrome Subjected to Percutaneous Coronary Intervention[NCT01774955] | 2,047 participants (Actual) | Observational [Patient Registry] | 2012-02-29 | Completed | |||
| Heart Rate Lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease[NCT01365286] | Phase 4 | 40 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
12 reviews available for practolol and Myocardial Infarction
| Article | Year |
|---|---|
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 12. Beta-adrenoceptor blockade in myocardial infarction: the continuing controversy.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudd | 1980 |
[Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics].
Topics: Adrenergic beta-Antagonists; Alprenolol; Anti-Arrhythmia Agents; Aspirin; Dipyridamole; Female; Fibr | 1981 |
The use of beta blockers for the reduction of mortality after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Atenolol; Clinical Trials as Topic; Double-Blind Method; Fe | 1981 |
Beta blocking agents: current status in the prevention of sudden coronary death.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Atenolol; Clinical Trials as Topic; Coronary D | 1982 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coron | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans | 1984 |
[Therapeutic value of the long-term administration of beta-adrenergic blockaders after myocardial infarct].
Topics: Adrenergic beta-Antagonists; Alprenolol; Clinical Trials as Topic; Humans; Metoprolol; Myocardial In | 1984 |
[Preventive effects of beta-blockers on myocardial infarction and on cardiac accidents following a first infarct].
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Angina Pectoris; Clinical Trials as Topic; Humans; Hy | 1978 |
Myocardial infarction size: measurement and modification.
Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Coronary Disease; Creatine Kinase; Digitalis Glycoside | 1977 |
Immunologic diseases of the pleura.
Topics: Adult; Aged; Bromocriptine; Cardiac Surgical Procedures; Collagen Diseases; Dantrolene; Female; Gran | 1985 |
Beta-adrenergic receptor blocking drugs in cardiac arrhythmias.
Topics: Action Potentials; Adrenergic beta-Antagonists; Alprenolol; Arrhythmia, Sinus; Arrhythmias, Cardiac; | 1974 |
Beta-Blockers in the management of myocardial ischemia.
Topics: Acute Disease; Adrenergic beta-Antagonists; Angina Pectoris; Cardiac Volume; Coronary Disease; Depre | 1974 |
34 trials available for practolol and Myocardial Infarction
| Article | Year |
|---|---|
Implementation of contemporary oral antiplatelet treatment guidelines in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a report from the GReek AntiPlatelet rEgistry (GRAPE).
Topics: Acute Coronary Syndrome; Adenosine; Administration, Oral; Aged; Clopidogrel; Combined Modality Thera | 2013 |
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 12. Beta-adrenoceptor blockade in myocardial infarction: the continuing controversy.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudd | 1980 |
The use of beta blockers for the reduction of mortality after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Atenolol; Clinical Trials as Topic; Double-Blind Method; Fe | 1981 |
Beta blockade and the secondary prevention of myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Clinical Trials as Topic; Double-Blind Method; Female | 1981 |
Beta blockers after myocardial infarction--aspects on study design based on current knowledge.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Clinical Trials as Topic; Female; Humans; Male; Middl | 1981 |
Beta blocking agents: current status in the prevention of sudden coronary death.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Atenolol; Clinical Trials as Topic; Coronary D | 1982 |
Prenalterol in the treatment of congestive heart failure developing during beta-blocking therapy. A comparison with frusemide in patients with acute myocardial infarction.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Blood Pressure; Dose-Response Relationship, D | 1982 |
Secondary prevention with beta-adrenoceptor blockers in post-myocardial infarction patients.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Double-Blind Method; Humans; Metoprolol; Myoc | 1982 |
Beta-blockers and myocardial infarction: infarction and ischaemia in the practolol and propranolol trials.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Coronary Disease; Electrocardiography; Humans | 1983 |
Chronic beta blockade therapy in patients after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Clinical Trials as Topic; Double-Blind Method; Humans | 1983 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coron | 1984 |
Hemodynamic trial of sequential treatment with diuretic, vasodilator, and positive inotropic drugs in left ventricular failure following acute myocardial infarction.
Topics: Adrenergic beta-Agonists; Adult; Cardiotonic Agents; Drug Therapy, Combination; Furosemide; Heart Fa | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans | 1984 |
[Therapeutic value of the long-term administration of beta-adrenergic blockaders after myocardial infarct].
Topics: Adrenergic beta-Antagonists; Alprenolol; Clinical Trials as Topic; Humans; Metoprolol; Myocardial In | 1984 |
Very early intervention with beta-blockade in acute myocardial infarction.
Topics: Clinical Trials as Topic; Humans; Myocardial Infarction; Practolol; Prognosis | 1984 |
The effect of a selective beta adrenergic blocking agent on ventricular arrhythmias in the first year following myocardial infarction.
Topics: Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Double-Blind Method; Electrocardiograph | 1980 |
[Use of adrenergic beta receptor blockaders in myocardial infarct].
Topics: Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Myoc | 1980 |
Preventing the second infarct.
Topics: Adult; Animals; Clinical Trials as Topic; Death, Sudden; Dogs; Electrocardiography; Exercise Therapy | 1980 |
A comparative study of cardioselective beta-blockade and diazepam in patients wtih acute myocardial infarction and tachycardia.
Topics: Age Factors; Aged; Blood Gas Analysis; Blood Pressure; Body Temperature; Diazepam; Female; Humans; M | 1980 |
Hemodynamic effects of combined treatment with lignocaine, procainamide and practolol in acute myocardial infarction.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Heart Ventricles; Hemodynamics; Humans; Lidocaine; M | 1980 |
Double-blind study of the effect of cardioselective beta-blockade on chest pain in acute myocardial infarction.
Topics: Acute Disease; Adrenergic beta-Antagonists; Blood Pressure; Clinical Trials as Topic; Heart Rate; Hu | 1976 |
Beta-adrenergic blocking agents in prevention of sudden death.
Topics: Acute Disease; Adrenergic beta-Antagonists; Alprenolol; Clinical Trials as Topic; Death, Sudden; Dru | 1978 |
[Preventive effects of beta-blockers on myocardial infarction and on cardiac accidents following a first infarct].
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Angina Pectoris; Clinical Trials as Topic; Humans; Hy | 1978 |
Effects of long-term practolol therapy on plasma-lipids after acute myocardial infarction.
Topics: Adult; Aged; Body Weight; Cholesterol; Clinical Trials as Topic; Electrophoresis; Female; Follow-Up | 1975 |
Practolol in acute myocardial infarction.
Topics: Acute Disease; Adult; Aged; Clinical Trials as Topic; Constipation; Drug Eruptions; Female; Humans; | 1976 |
Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol. A multicentre international study.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Clinical Trials as Topic; Death, Sudden; Evaluation Stu | 1975 |
Rapid monitoring of regional myocardial ischaemia with echocardiography and ST segment shifts in man. Modification of "infarct size" and hemodynamics by dopamine and beta blockade.
Topics: Acute Disease; Adult; Aged; Dopamine; Echocardiography; Female; Hemodynamics; Humans; Male; Middle A | 1978 |
Exercise induced tachycardia after cessation of practolol therapy.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Heart Rate; Humans; Male; Middle Aged; M | 1977 |
Reduction in mortality after myocardial infarction with long-term beta-adrenoceptor blockade. Multicentre international study: supplementary report.
Topics: Arrhythmias, Cardiac; Clinical Trials as Topic; Humans; Myocardial Infarction; Practolol; Prognosis; | 1977 |
Intravenous and oral practolol in the acute stages of myocardial infarction.
Topics: Acute Disease; Aged; Arrhythmias, Cardiac; Blood Pressure; Dose-Response Relationship, Drug; Follow- | 1978 |
Proceedings: Effects of cardioselective beta-blockers on chest pain, ECG, and heart function in acute myocardial infarction.
Topics: Clinical Trials as Topic; Electrocardiography; Heart; Humans; Myocardial Infarction; Pain; Practolol | 1976 |
Letter: Long-term prophylaxis with beta-adrenoceptor blockade after myocardial infarction.
Topics: Clinical Trials as Topic; Follow-Up Studies; Humans; Myocardial Infarction; Practolol | 1975 |
[Treatment of arrhythmias with practolol (Eraldin)].
Topics: Acute Disease; Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Arteriosclerosis; Atrial Fib | 1973 |
[Effects of LBI45, practolol and a placebo on the exercise tests of coronary patients. A double-blind study (author's transl)].
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Drug Combinations; Electroca | 1974 |
84 other studies available for practolol and Myocardial Infarction
| Article | Year |
|---|---|
Haemodynamic effects of prenalterol in patients with coronary heart disease.
Topics: Adrenergic beta-Agonists; Blood Pressure; Coronary Disease; Heart Rate; Heart Ventricles; Hemodynami | 1980 |
[Use of beta-adrenergic blocking agents in acute myocardial infarction (author's transl)].
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Coronary Circulation; Creatine Kinase; Electroc | 1981 |
Hemodynamic and cardiometabolic effects of prenalterol in patients with acute myocardial infarction and shock.
Topics: Adrenergic beta-Agonists; Aged; Blood Pressure; Cardiac Output; Humans; Lactates; Lactic Acid; Male; | 1981 |
[Beta blockage after myocardial infarct].
Topics: Adrenergic beta-Antagonists; Alprenolol; Humans; Myocardial Infarction; Practolol; Propranolol; Time | 1982 |
Comparative investigation of the effects of metoprolol, propranolol, practolol, and verapamil in the acute phase of experimental myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Blood Pressure; Calcium Channel Blockers | 1982 |
Clinical experiences with prenalterol as an antidote to Beta-adrenoceptor blockade.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Anesthesia; Cardiac Catheterizat | 1982 |
Haemodynamic effects of intravenously administered prenalterol in patients with severe heart failure.
Topics: Adrenergic beta-Agonists; Aged; Blood Pressure; Coronary Disease; Female; Heart; Heart Failure; Hear | 1982 |
The hemodynamic actions of prenalterol in left ventricular failure.
Topics: Adrenergic beta-Agonists; Aged; Blood Pressure; Cardiac Catheterization; Cardiac Output; Dose-Respon | 1982 |
Effects of i.v. prenalterol in patients with severe cardiac failure at rest and during exercise.
Topics: Adrenergic beta-Agonists; Cardiac Catheterization; Cardiac Output; Cardiomyopathies; Female; Heart; | 1982 |
[Use of prenalterol in cardiogenic shock occurring in acute myocardial infarct].
Topics: Adrenergic beta-Agonists; Cardiotonic Agents; Drug Evaluation; Humans; Myocardial Infarction; Practo | 1982 |
Prenalterol in cardiogenic shock following acute myocardial infarction.
Topics: Adrenergic beta-Agonists; Aged; Female; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Ag | 1984 |
Effects of beta-adrenergic inhibition on scar formation after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Cicatrix; Dogs; Electrocardiography; Endocardium; Heart Ventri | 1984 |
Haemodynamic effects of prenaterol and cardiac glycosides in patients with recent myocardial infarction.
Topics: Adrenergic beta-Agonists; Aged; Blood Pressure; Cardiac Output; Digoxin; Drug Therapy, Combination; | 1984 |
Apparent superiority of H2-receptor stimulation and simultaneous beta-blockade over conventional treatment with beta-sympathomimetic drugs in post-acute myocardial infarction: cardiac effects of impromidine--a new specific H2-receptor agonist-in the survi
Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Animals; Binding Sites; Dobutamine; Female; Guinea P | 1984 |
[Hemodynamic effects of a new beta-1 stimulating drug (prenalterol) in acute myocardial infarct in the open-chest pig].
Topics: Adrenergic beta-Agonists; Animals; Hemodynamics; Myocardial Contraction; Myocardial Infarction; Prac | 1982 |
Mortality after recovery from myocardial infarction.
Topics: Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Death, Sudden; Heart Failure; Humans; Myocardi | 1980 |
[Possibilities of limiting the extent of myocardial infarct and correction of biochemical disorders by infusion of practolol].
Topics: Adult; Aged; Creatine Kinase; Fatty Acids, Nonesterified; Female; Humans; Infusions, Parenteral; Lac | 1983 |
Regional myocardial contractile response to the beta-adrenergic stimulant prenalterol in the conscious dog following myocardial infarction. Mechanism of hemodynamic effect.
Topics: Animals; Dogs; Electrocardiography; Heart Rate; Male; Myocardial Contraction; Myocardial Infarction; | 1984 |
[Hemodynamic effects of a new beta-1 stimulating drug (prenalterol) in acute myocardial infarct in swine with open thorax].
Topics: Animals; Aorta; Blood Circulation; Drug Evaluation, Preclinical; Heart Rate; Myocardial Infarction; | 1982 |
Central and peripheral haemodynamic effects of prenalterol in patients with coronary heart disease.
Topics: Blood Pressure; Cardiac Output; Female; Forearm; Heart; Heart Rate; Hemodynamics; Humans; Injections | 1981 |
Influence of parasympathetic pathways on early post--infarction arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Atropine; Blood Pressure; Heart Rate; Myocardial Infarction; Parasymp | 1980 |
The effect of beta-blockade on ST segment elevation after acute myocardial infarction in man with some experimental observations.
Topics: Acute Disease; Adrenergic beta-Antagonists; Coronary Circulation; Heart Rate; Humans; Isoproterenol; | 1976 |
Editorial: Beta adrenergic blockade for prophylaxis against recurrent myocardial infarction and sudden death.
Topics: Adrenergic beta-Antagonists; Coronary Disease; Death, Sudden; Humans; Myocardial Infarction; Practol | 1976 |
Prophylactic antiarrhythmic drugs after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Age Factors; Alprenolol; Anti-Arrhythmia Agents; Humans; Middle Aged; M | 1976 |
Interaction of anesthesia, beta-receptor blockade, and blood loss in dogs with induced myocardial infarction.
Topics: Acetylcholine; Adrenergic beta-Antagonists; Anesthesia, General; Animals; Coronary Circulation; Dogs | 1976 |
The effect of beta-adrenoreceptive antagonists on the morbidity and mortality in cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Animals; Coronary Disease; Dogs; Follow-Up | 1976 |
Beta adrenergic blockade, regional left ventricular blood flow and ST-segment elevation in canine experimental myocardial ischemia.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Circulation; Dogs; Electrocardiography; Female; Hemod | 1978 |
Factors influencing the infarct: the place of beta-blockade in limiting infarct size.
Topics: Adrenergic beta-Antagonists; Creatine Kinase; Humans; Myocardial Infarction; Practolol; Rest | 1978 |
The role of long term beta-blockade after myocardial infarction: Paper 3.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Humans; Myocardial Infarction; Practolol; | 1978 |
Letter: Role of catecholamines in arrhythmias after acute myocardial infarction.
Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Catecholamines; Dogs; Heart; Humans; Myocardial Infarc | 1975 |
Beneficial effect of practolol in preventing adrenaline-induced systemic and myocardial metabolic changes.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Dogs; Epinephrine; Fatty Acids, Nonesterifie | 1979 |
Long-term beta blockade: possible protection from myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aspartate Aminotransferases; Blood Sedimentation; Body Temperature; Cor | 1975 |
Beta blocking drugs as anti-arrhythmic agents.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Anura; Arrhythmias, Cardiac; Atrial Fibrill | 1975 |
Electrophysiology and pharmacology of cardiac arrhythmias. IX. Cardiac electrophysiologic effects of beta adrenergic receptor stimulation and blockade. Part B.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Arrhythmia, Sin | 1975 |
[Assessment of early arrhythmias in acute experimental myocardial infarct in rabbits].
Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Coronary Vessels; Female; Heart Conduction System; Lig | 1978 |
Incidence of ventricular arrhythmias in first year after myocardial infarction.
Topics: Adult; Aged; Arrhythmias, Cardiac; Aspartate Aminotransferases; Electrocardiography; Female; Heart F | 1978 |
Superiority of practolol versus propranolol in protection against ventricular fibrillation induced by coronary occlusion.
Topics: Animals; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Male; Myocard | 1978 |
Measurement of stroke volume from pulmonary artery pressure record in man.
Topics: Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiomyopathy, Hypertrophic; Catecholamine | 1975 |
Toward preventing coronary death from ventricular fibrillation.
Topics: Adult; Aged; Angina Pectoris; Coronary Artery Bypass; Coronary Disease; Death, Sudden; Humans; Hyper | 1976 |
Effects of long-term therapy of propranolol and practolol on plasma-lipids after acute myocardial infarction.
Topics: Acute Disease; Adult; Aged; Female; Humans; Lipids; Male; Middle Aged; Myocardial Infarction; Practo | 1977 |
Management of the acute coronary attack.
Topics: Acute Disease; Autonomic Nervous System; Coronary Disease; Electric Countershock; Emergencies; Human | 1977 |
Comparative effects of propranolol and practolol in the early stages of experimental canine myocardial infarction.
Topics: Animals; Body Temperature; Coronary Circulation; Coronary Vessels; Dipyridamole; Dogs; Female; Hemod | 1976 |
Pathology of practolol-induced ocular toxicity.
Topics: Aged; Angina Pectoris; Conjunctiva; Cornea; Epithelium; Eye; Eye Diseases; Female; Humans; Hypertens | 1976 |
Improvement in prognosis of myocardial infarction by long-term beta-adrenoceptor blockade.
Topics: Animals; Blood Pressure; Death, Sudden; Humans; Myocardial Infarction; Practolol; Prognosis; Recurre | 1976 |
[Ocular complications following practolol administration].
Topics: Eye Diseases; Female; Humans; Light; Middle Aged; Myocardial Infarction; Practolol; Skin Manifestati | 1976 |
Hierarchy of ventricular pacemakers.
Topics: Animals; Bundle of His; Disease Models, Animal; Dogs; Electrocardiography; Epinephrine; Heart; Heart | 1976 |
Effect of cardioselective beta-blockade on heart function and chest pain in acute myocardial infarction.
Topics: Acute Disease; Blood Pressure; Heart; Heart Rate; Humans; Myocardial Contraction; Myocardial Infarct | 1976 |
Letter: Duration of action of practolol.
Topics: Exercise Test; Half-Life; Heart Rate; Humans; Myocardial Infarction; Placebos; Practolol; Time Facto | 1975 |
Letter: Postoperative myocardial infarction.
Topics: Humans; Myocardial Infarction; Postoperative Complications; Practolol; Risk | 1975 |
Effect of practolol on left ventricular dimensions during coronary occlusion.
Topics: Animals; Coronary Disease; Dogs; Heart; Hemodynamics; Myocardial Contraction; Myocardial Infarction; | 1975 |
Is there still a place for practolol?
Topics: Arrhythmias, Cardiac; Humans; Myocardial Infarction; Practolol | 1975 |
[Experimental studies on the use of beta-sympatholytics in infarct-induced ventricular fibrillation].
Topics: Animals; Dogs; Drug Combinations; Myocardial Infarction; Practolol; Propranolol; Sympatholytics; Ven | 1975 |
Letter: Long-term postinfarction treatment with practolol.
Topics: Alprenolol; Blood Pressure; Humans; Myocardial Infarction; Practolol | 1975 |
[The use of beta-blocking agents in acute cardiac infarct].
Topics: Adult; Aged; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; Myocardial Infarction; Practol | 1975 |
[The effect of atenolol on contractility and hemodynamics of the infarcted heart in comparison to propranolol and practolol (author's transl)].
Topics: Animals; Atenolol; Blood Pressure; Cardiac Output; Coronary Circulation; Dogs; Dose-Response Relatio | 1975 |
Letter: Long-term postinfarction treatment with practolol.
Topics: Blood Pressure; Humans; Myocardial Infarction; Practolol | 1976 |
Failure of ST segment elevation to predict severity of acute myocardial infarction.
Topics: Adult; Aged; Creatine Kinase; Heart; Humans; Middle Aged; Myocardial Infarction; Myocardium; Practol | 1976 |
Diseases of the cardiovascular system. Management of acute myocardial infarction.
Topics: Atropine; Bradycardia; Coronary Care Units; Electric Countershock; Heart Arrest; Humans; Myocardial | 1976 |
Influence of sympathetic withdrawal on early postinfarction arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Female; Ganglia, Sympathetic; Heart Rate; Male; Myoca | 1987 |
Chronic infarction decreases maximum cardiac work and sensitivity of heart to extracellular calcium.
Topics: Adenosine Triphosphate; Adrenergic beta-Agonists; Animals; Blood Pressure; Calcium; Creatine Kinase; | 1985 |
[Curve form of serum creatinine kinase MB isoenzyme activity and the clinical course and type of treatment of acute myocardial infarction].
Topics: Aged; Creatine Kinase; Humans; Isoenzymes; Middle Aged; Myocardial Infarction; Nitroglycerin; Practo | 1987 |
The correlation between CK MB curve type and the clinical course of recent myocardial infarction.
Topics: Adult; Aged; Creatine Kinase; Heart Failure; Humans; Isoenzymes; Middle Aged; Myocardial Infarction; | 1988 |
Falsely favourable early prognosis for continuing smokers following recovery from acute myocardial infarction. Information from the multi-centre practolol trial.
Topics: Humans; Middle Aged; Myocardial Infarction; Practolol; Prognosis; Recurrence; Smoking; Time Factors | 1987 |
Heart-rate changes during movement of patients with acute myocardial infarction.
Topics: Adult; Aged; Atropine; Coronary Care Units; Depression, Chemical; Heart Rate; Humans; Middle Aged; M | 1974 |
Diamorphine-induced attack of paroxysmal hypertension in phaeochromocytoma.
Topics: Catecholamines; Cyclizine; Diplopia; Electrocardiography; Fecal Impaction; Headache; Heart Rate; Her | 1974 |
[Practolol in cardiac arrhythmias].
Topics: Acute Disease; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Compl | 1974 |
[Panel discussion: Evaluation of the antiarrhythmic drugs and current problems associated with their use in clinical practice (author's transl)].
Topics: Administration, Oral; Ajmaline; Aniline Compounds; Animals; Anti-Arrhythmia Agents; Cardiac Complexe | 1974 |
Editorial: Beta-blockade and size of acute myocardial infarction.
Topics: Acute Disease; Administration, Oral; Animals; Dogs; Heart; Humans; Injections, Intravenous; Myocardi | 1974 |
[Exercise test in the evaluation of effectiveness of 4 antianginal drugs (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Exercise Test; Humans; Isosorbide Dinitrate; Ma | 1974 |
[The influence of beta receptor blockade on the incidence of postoperative cardiovascular complications (author's transl)].
Topics: Adrenergic beta-Antagonists; Heart Failure; Humans; Myocardial Infarction; Postoperative Complicatio | 1974 |
[Effects of selective beta adrenergic block on myocardial contractility. Relative role of negative inotropic and chronotropic effects].
Topics: Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Cardiac Volume; Cardiomyopathies; Electric Sti | 1974 |
Practolol in cardiac arrhythmias.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Digitalis Glycosides; Female; Humans; Male; Middle Ag | 1974 |
The problems of treating disturbances of heart rhythm at home.
Topics: Arrhythmias, Cardiac; Atropine; Cardiac Glycosides; Digoxin; Home Nursing; Humans; Lidocaine; Myocar | 1974 |
Apex cardiogram and systolic time intervals in acute myocardial infarction and effects of practolol.
Topics: Acute Disease; Angina Pectoris; Blood Pressure; Cardiac Output; Electrocardiography; Heart Rate; Hum | 1974 |
Proceedings: The effects of practolol in the early stages of experimental myocardial infarction.
Topics: Animals; Dogs; Heart; Heart Rate; Hemodynamics; Isoproterenol; Myocardial Infarction; Myocardium; Ox | 1974 |
[Electrophysiological effects of practolol in patients with acute myocardial infarct].
Topics: Acute Disease; Aged; Bundle of His; Evoked Potentials; Female; Humans; Male; Middle Aged; Myocardial | 1974 |
Heart motion video-tracking in the assessment of cardiac performance.
Topics: Cardiomyopathies; Coronary Artery Bypass; Coronary Disease; Depression, Chemical; Heart; Heart Ventr | 1974 |
[Effects on the contractile state of the myocardium and anti-arrhythmic properties of practolol, a beta-blocking agent with cardioselective activity].
Topics: Adult; Arrhythmias, Cardiac; Heart; Humans; Male; Middle Aged; Myocardial Infarction; Practolol | 1972 |
Systemic lupus erythematosus and acute myocardial infarction.
Topics: Acute Disease; Adult; Female; Humans; Hydrocortisone; Lupus Erythematosus, Systemic; Middle Aged; My | 1973 |
Hemodynamic studies on patients with acute myocardial infarct following Pracolol administration.
Topics: Adult; Aged; Female; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial In | 1973 |
The hemodynamic effects of practolol in experimental myocardial infarction.
Topics: Animals; Cardiac Output; Coronary Vessels; Disease Models, Animal; Dogs; Heart Rate; Hemodynamics; L | 1973 |
Combined use of glucagon and beta-adrenoceptor antagonists in ventricular arrhythmias accompanying myocardial infarction.
Topics: Animals; Arrhythmias, Cardiac; Dogs; Drug Synergism; Glucagon; Myocardial Infarction; Practolol; Pro | 1973 |
Proceedings: A comparison of the effects of practolol and propranolol on the response to haemorrhage in anaesthetized dogs after myocardial infarction.
Topics: Animals; Dogs; Hemodynamics; Hemorrhage; Myocardial Infarction; Practolol; Propranolol | 1973 |
[Lidocaine and practolol therapy of infarction caused arrhythmias].
Topics: Animals; Arrhythmias, Cardiac; Dogs; Drug Interactions; Lidocaine; Myocardial Infarction; Practolol | 1973 |